GHO Capital acquires Scientist.com, the leading AI-powered R&D orchestration platform
16.9.2025 13:00:00 CEST | GlobeNewswire by notified | Press release
GHO Capital acquires Scientist.com, the leading AI-powered R&D orchestration platform
Transaction underscores GHO’s strategy of backing category leaders across preclinical and clinical R&D services
• Scientist.com is the market-leading digital platform for outsourced R&D, trusted by the world’s top biopharma companies and thousands of pre-vetted suppliers of scientific services and products.
• GHO’s deep sector knowledge and proven record of scaling life sciences businesses will accelerate Scientist.com's next phase of global growth.
London, UK — 16 September 2025: GHO Capital Partners LLP (“GHO”), the specialist investor in global healthcare, today announces it has entered into a definitive agreement to acquire Scientist.com, the AI-powered R&D orchestration platform that enables pharmaceutical and biotech companies to source and manage outsourced research from a global network of pre-approved suppliers.
The acquisition expands GHO’s portfolio of category-leading companies delivering innovative solutions that improve efficiency, compliance, and impact across healthcare and life sciences. Scientist.com’s sector focus on pharmaceutical R&D services, biotechnology, life science tools, and contract research aligns directly with GHO’s areas of deep expertise. Together, the partnership creates powerful synergies to fuel Scientist.com’s expansion through global reach, strategic partnerships, and selective acquisitions.
Biopharma R&D procurement processes remain fragmented and manual, creating inefficiencies and compliance risks, particularly in highly regulated, complex research and clinical markets. Scientist.com solves this by connecting pharmaceutical and biotech companies to a curated, global network of pre-vetted suppliers on one intelligent platform. At its core is a powerful AI engine that streamlines the entire outsourced research process – from supplier qualification and compliance enforcement to intelligent vendor matching, automated contract drafting, predictive project modelling, and smart negotiation tools – within one seamless platform. Created by scientists for scientists, the platform accelerates high-value R&D while navigating the realities of complex procurement, transforming how organisations source innovation.
Edward de Nor and Stuart Quin, Partners at GHO, said: “Scientist.com is a category-defining platform that transforms how biopharma companies manage R&D procurement, seamlessly integrating software, data, and outsourced services. The alignment between our expertise in pharmaceutical R&D, biotechnology, and life science tools, and Scientist.com's market leadership, creates a unique opportunity to accelerate its growth. We are excited to partner with the team to expand global adoption and advance innovation, in line with our mission to deliver better, faster, more accessible healthcare.”
Kevin Lustig, PhD, Andy Martin, PhD and Chris Petersen, Founders of Scientist.com, commented: “GHO’s expertise across our key market segments and track record of scaling innovative leaders make them the ideal partner to help us scale globally. Together, we can put outsourced R&D ‘on rails’, delivering shorter timelines, stronger governance, and clearer visibility from concept to clinic.”
Based in Solana Beach, California, Scientist.com is a global leader in life sciences R&D procurement, trusted by the world’s largest pharmaceutical companies, hundreds of biotech firms, and thousands of suppliers. The platform provides an end-to-end compliance solution that unifies supplier discovery, bidding, contracting, compliance, and spend analytics within a secure ecosystem. This enables users to achieve double-digit percentage cost savings while cutting project timelines from months to days. With a first-mover advantage and over a decade of growth, Scientist.com is the trusted partner for companies seeking to optimise their external R&D procurement.
Advisors
GHO was advised by Ropes & Gray, ClearView Healthcare Partners, West Monroe, and Deloitte.
Scientist.com was advised by Union Square Advisors and Wilson Sonsini.
Further information:
GHO Capital Partners LLP
T +44 20 3700 7440
For Media Enquiries:
ICR Healthcare Tel: +44 (0) 20 3709 5700 or ghocapital@icrhealthcare.com
Amber Fennell, Kris Lam
About GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor headquartered in London. We apply global capabilities and perspectives to unlock high growth healthcare opportunities, targeting Pan-European and transatlantic internationalisation to build market-leading businesses of strategic global value. Our proven investment track record reflects the unrivalled depth of our industry expertise and network. We partner with strong management teams to generate long-term sustainable value, improving the efficiency of healthcare delivery to enable better, faster, more accessible healthcare. For further information, please visit www.ghocapital.com.
About Scientist.com
Scientist.com is the leading AI-enabled R&D orchestration platform for the life science industry. The platform simplifies drug discovery and clinical development by streamlining procurement, accelerating innovation, ensuring regulatory compliance and connecting scientists with a global network of pre-qualified suppliers. Scientist.com powers private marketplaces for many of the world’s largest pharmaceutical companies and hundreds of biotech firms. The company is headquartered in Solana Beach, California. For more information, please visit www.scientist.com.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Iveco Group signs a 150 million euro term loan facility with Cassa Depositi e Prestiti to support investments in research, development and innovation11.6.2024 12:00:00 CEST | Press release
Turin, 11th June 2024. Iveco Group N.V. (EXM: IVG), a global automotive leader active in the Commercial & Specialty Vehicles, Powertrain and related Financial Services arenas, has successfully signed a term loan facility of 150 million euros with Cassa Depositi e Prestiti (CDP), for the creation of new projects in Italy dedicated to research, development and innovation. In detail, through the resources made available by CDP, Iveco Group will develop innovative technologies and architectures in the field of electric propulsion and further develop solutions for autonomous driving, digitalisation and vehicle connectivity aimed at increasing efficiency, safety, driving comfort and productivity. The financed investments, which will have a 5-year amortising profile, will be made by Iveco Group in Italy by the end of 2025. Iveco Group N.V. (EXM: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a
DSV, 1115 - SHARE BUYBACK IN DSV A/S11.6.2024 11:22:17 CEST | Press release
Company Announcement No. 1115 On 24 April 2024, we initiated a share buyback programme, as described in Company Announcement No. 1104. According to the programme, the company will in the period from 24 April 2024 until 23 July 2024 purchase own shares up to a maximum value of DKK 1,000 million, and no more than 1,700,000 shares, corresponding to 0.79% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (“MAR”) (save for the rules on share buyback programmes set out in MAR article 5) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. Trading dayNumber of shares bought backAverage transaction priceAmount DKKAccumulated trading for days 1-25478,1001,023.01489,100,86026:3 June 20247,0001,050.597,354,13027:4 June 20245,0001,055.705,278,50028:6 June20243,0001,096.273,288,81029:7 June 20244,0001,106.174,424,68
Landsbankinn hf.: Offering of covered bonds11.6.2024 11:16:36 CEST | Press release
Landsbankinn will offer covered bonds for sale via auction held on Thursday 13 June at 15:00. An inflation-linked series, LBANK CBI 30, will be offered for sale. In connection with the auction, a covered bond exchange offering will take place, where holders of the inflation-linked series LBANK CBI 24 can sell the covered bonds in the series against covered bonds bought in the above-mentioned auction. The clean price of the bonds is predefined at 99,594. Expected settlement date is 20 June 2024. Covered bonds issued by Landsbankinn are rated A+ with stable outlook by S&P Global Ratings. Landsbankinn Capital Markets will manage the auction. For further information, please call +354 410 7330 or email verdbrefamidlun@landsbankinn.is.
Relay42 unlocks customer intelligence with a new insights and reporting module, powered by Amazon QuickSight11.6.2024 11:00:00 CEST | Press release
AMSTERDAM, June 11, 2024 (GLOBE NEWSWIRE) -- Relay42, a leading European Customer Data Platform (CDP), is leveraging Amazon QuickSight to power its new real-time customer intelligence, reporting, and dashboard module. Harnessing the breadth and quality of customer data, the new Insights module empowers marketing teams to dive deep into customer behaviors and gain invaluable insights into the performance of their marketing programs across all online, offline, paid, and owned marketing channels. Preview of the Relay42 Insights module, in pre-beta version Key capabilities of the Relay42 Insights module include: Deep insights into customer behaviors: With the Relay42 Insights module, marketers can ask unlimited questions about their data and gain a deeper understanding of how to serve their customers more effectively. Simplicity with AI-powered querying: Marketers can use artificial intelligence to query their data using natural language search, reducing the reliance on data scientists. Us
Metasphere Labs Announces X Spaces Event on the Topic of Green Bitcoin Mining and Sound Money for Sustainability11.6.2024 10:30:00 CEST | Press release
VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere Labs" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is thrilled to announce an engaging Twitter Spaces event on Green Bitcoin mining, energy markets, and sustainability on July 3, 2024 at 2 p.m. ET. Follow us on X at MetasphereLabs for updates and to join the event. What We'll Discuss Bitcoin Mining Basics: Understand the fundamentals of Bitcoin mining.Energy Market Dynamics: Explore how Bitcoin mining interacts with energy markets.Sustainable Innovations: Learn about our efforts to promote sustainability in Bitcoin mining.Sound Money: Discover how tamper-proof currency can enhance stability.Efficient Payment Rails: See how fast, neutral payment systems support humanitarian projects.Carbon Footprint: Compare Bitcoin's environmental impact with traditional banking. "We're excited to host this event and dive into the critical topics of Bitcoin